fluorodeoxyglucose f18 has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, L; Lai, H; Li, X; Liang, Z; Qiao, H; Song, Y; Sun, J; Wang, CD; Wu, T; Xu, F; Yan, Z; Yao, T; Ye, C; Zhang, D | 1 |
| Alberici, A; Boccone, L; Borroni, B; Brusco, A; Caruso, D; Costanzi, C; Di Gregorio, E; Ferrero, M; Grassi, M; Manes, M; Mitro, N; Orsi, L; Padovani, A; Paghera, B; Pani, C; Pasolini, MP; Perani, D; Premi, E; Tempia, F; Zoppo, A | 1 |
| Alberici, A; Boccone, L; Borroni, B; Brusco, A; Caruso, D; Costanzi, C; Di Gregorio, E; Ferrero, M; Manes, M; Mitro, N; Orsi, L; Padovani, A; Paghera, B; Pani, C; Pasolini, MP; Premi, E; Tempia, F | 1 |
| Chung, SJ; Kim, JS; Oh, JS; Oh, M | 1 |
| Brockmann, K; Globas, C; Hauser, TK; Machulla, HJ; Reimold, M; Rolfs, A; Schöls, L; Walter, U | 1 |
| Brien, MO; Giunti, P; Khan, NL; Lees, AJ; Piccini, P; Scherfler, C; Sweeney, MG; Wood, NW | 1 |
| Abele, M; Bares, R; Bürk, K; Dohmen, BM; Klockgether, T; Machulla, HJ; Minnerop, M; Reimold, M; Wüllner, U | 1 |
| Liu, RS; Soong, BW; Wang, PS; Yang, BH | 2 |
| Lee , H; Liu , R; Lu , Y; Soong , B; Wu , L | 1 |
3 trial(s) available for fluorodeoxyglucose f18 and Autosomal Dominant Cerebellar Ataxia, Type II
| Article | Year |
|---|---|
Docosahexaenoic acid is a beneficial replacement treatment for spinocerebellar ataxia 38.
Topics: Adult; Ataxins; Brain; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Electromyography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Mutation; Outcome Assessment, Health Care; Positron-Emission Tomography; Spinocerebellar Ataxias; Treatment Outcome | 2017 |
Long-term efficacy of docosahexaenoic acid (DHA) for Spinocerebellar Ataxia 38 (SCA38) treatment: An open label extension study.
Topics: Adult; Docosahexaenoic Acids; Electric Stimulation; Electromyography; Fatty Acid Elongases; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Spinocerebellar Ataxias | 2019 |
Metabolic characterization of spinocerebellar ataxia type 6.
Topics: Adult; Cerebellum; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Radiopharmaceuticals; Spinocerebellar Ataxias; Statistics, Nonparametric; Telencephalon; Tomography, Emission-Computed | 2001 |
7 other study(ies) available for fluorodeoxyglucose f18 and Autosomal Dominant Cerebellar Ataxia, Type II
| Article | Year |
|---|---|
Clinical and Preclinical Neuroimaging Changes in Spinocerebellar Ataxia Type 12: A Study of Three Chinese Pedigrees.
Topics: Atrophy; China; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neuroimaging; Pedigree; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Spinocerebellar Ataxias | 2022 |
Cerebellum-specific 18F-FDG PET analysis for the detection of subregional glucose metabolism changes in spinocerebellar ataxia.
Topics: Adult; Brain Mapping; Cerebellum; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Signal Processing, Computer-Assisted; Spinocerebellar Ataxias | 2014 |
PET and MRI reveal early evidence of neurodegeneration in spinocerebellar ataxia type 17.
Topics: Adult; Age of Onset; Brain; Dopamine Agents; Dopamine Antagonists; Dopaminergic Neurons; Female; Fluorodeoxyglucose F18; Glucose; Heterozygote; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methylphenidate; Middle Aged; Mutation; Neurodegenerative Diseases; Neuropsychological Tests; Positron-Emission Tomography; Raclopride; Radiopharmaceuticals; Spinocerebellar Ataxias | 2012 |
Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6).
Topics: Adult; Aged; Aged, 80 and over; Calcium Channels; Corpus Striatum; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinsonian Disorders; Pedigree; Phenotype; Point Mutation; Positron-Emission Tomography; Spinocerebellar Ataxias; Substantia Nigra; Trinucleotide Repeat Expansion | 2005 |
Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6.
Topics: Adult; Binding, Competitive; Biomarkers; Brain; Brain Mapping; Dopamine; Dopamine Plasma Membrane Transport Proteins; Down-Regulation; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Middle Aged; Nerve Tissue Proteins; Parkinsonian Disorders; Positron-Emission Tomography; Presynaptic Terminals; Spinocerebellar Ataxias | 2005 |
Topographic brain mapping of the international cooperative ataxia rating scale. A positron emission tomography study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain; Brain Mapping; Caudate Nucleus; Cerebellum; Disability Evaluation; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Male; Middle Aged; Neural Pathways; Olivopontocerebellar Atrophies; Positron-Emission Tomography; Reproducibility of Results; Spinocerebellar Ataxias; Thalamus | 2007 |
Regional patterns of cerebral glucose metabolism in spinocerebellar ataxia type 2, 3 and 6 : a voxel-based FDG-positron emission tomography analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Brain Mapping; Female; Fluorodeoxyglucose F18; Glucose; Humans; Machado-Joseph Disease; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Spinocerebellar Ataxias | 2007 |